These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 3912921)

  • 21. The effects of acetaldophosphamide, a novel stable aldophosphamide analogue, on normal human and leukemic progenitor cells in vitro: implications for use in bone marrow purging.
    Beran M; Andersson BS; Wang Y; McCredie KB; Farquhar D
    Cancer Res; 1988 Jan; 48(2):339-45. PubMed ID: 3275495
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Difference in kinetics of hematopoietic reconstitution between ALL and ANLL after autologous bone marrow transplantation with marrow treated in vitro with mafosfamide (ASTA Z 7557).
    Douay L; Laporte JP; Mary JY; Lopez M; Lemonnier MP; Stachowiak J; Benitez O; Deloux J; Najman A; Salmon C
    Bone Marrow Transplant; 1987 Jun; 2(1):33-43. PubMed ID: 3332155
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunological and pharmacological removal of small cell lung cancer cells from bone marrow autografts.
    Humblet Y; Feyens AM; Sekhavat M; Agaliotis D; Canon JL; Symann ML
    Cancer Res; 1989 Sep; 49(18):5058-61. PubMed ID: 2548708
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro active cyclophosphamide derivatives in cleansing procedures intended for autologous bone marrow transplantation.
    Manna A; Sparaventi G; Palazzi M; Porcellini A
    Haematologica; 1986; 71(3):257-61. PubMed ID: 3093332
    [No Abstract]   [Full Text] [Related]  

  • 25. Ex vivo chemopurging of autologous bone marrow with 4-hydroperoxycyclophosphamide to eliminate occult leukemic cells. Laboratory and clinical observations.
    Yeager AM; Rowley SD; Kaizer H; Santos GW
    Am J Pediatr Hematol Oncol; 1990; 12(3):245-56. PubMed ID: 2240470
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro purging of leukemia and solid tumor cells by merocyanine 540.
    Manna A; Marchetti-Rossi MT; Porcellini A
    Haematologica; 1987; 72(2):177-9. PubMed ID: 3114075
    [No Abstract]   [Full Text] [Related]  

  • 27. Immunological bone marrow purging procedure in Burkitt's lymphoma. Evaluation by a liquid cell culture assay.
    Favrot MC; Philip I; Maritaz O; Garçon N; Philip T
    Rev Fr Transfus Immunohematol; 1985 Nov; 28(5):455-62. PubMed ID: 3912923
    [No Abstract]   [Full Text] [Related]  

  • 28. Chromosome abnormalities after autologous bone marrow transplantation with marrow treated by cyclophosphamide derivatives.
    van den Akker J; Gorin NC; Laporte JP; Douay L; Lopez M; Taillemite JL; Najman A; Duhamel G
    Lancet; 1985 May; 1(8439):1211-2. PubMed ID: 2860404
    [No Abstract]   [Full Text] [Related]  

  • 29. Density gradient separation of hematopoietic stem cells in autologous bone marrow transplantation.
    Iacone A; Quaglietta AM; D'Antonio D; Accorsi P; Dragani A; Angrilli F; Berardi A; Angelini A; Di Bartolomeo P; Di Bartolomeo G
    Haematologica; 1991 Mar; 76 Suppl 1():18-21. PubMed ID: 1677910
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Purging leukemia remission marrows with alkyl-lysophospholipids, preclinical and clinical results.
    Vogler WR; Olson AC; Berdel WE; Okamoto S; Glasser L
    Prog Clin Biol Res; 1990; 333():1-18; discussion 19-20. PubMed ID: 2308973
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Highly efficient elimination of Philadelphia leukemic cells by exposure to bcr/abl antisense oligodeoxynucleotides combined with mafosfamide.
    Skorski T; Nieborowska-Skorska M; Barletta C; Malaguarnera L; Szcyzlik C; Chen ST; Lange B; Calabretta B
    J Clin Invest; 1993 Jul; 92(1):194-202. PubMed ID: 8325984
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ASTA Z 7557 (INN mafosfamide) for the in vitro treatment of human leukemic bone marrows.
    Douay L; Gorin NC; Laporte JP; Lopez M; Najman A; Duhamel G
    Invest New Drugs; 1984; 2(2):187-90. PubMed ID: 6381382
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lymphokine-activated killer (LAK) cell purging of leukemic bone marrow: range of activity against different hematopoietic neoplasms.
    Long GS; Cramer DV; Harnaha JB; Hiserodt JC
    Bone Marrow Transplant; 1990 Sep; 6(3):169-77. PubMed ID: 2252956
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro purging of bone marrow with mafosfamide synergizes with in vivo chemotherapy to delay the hematological recovery in a murine model of autologous bone marrow transplantation.
    Lopez M; Mary JY; Sainteny F
    Exp Hematol; 1993 Feb; 21(2):311-8. PubMed ID: 8425567
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Autologous bone marrow transplantation and pharmacological bone marrow purging: in vitro use of maphosphamide and bleomycin.
    Visani G; Rizzoli V; Dinota A; Aglietta M; Bernabei PA; Geraci L; Leoni P; Mangoni L; Meloni G; Motta MR
    Haematologica; 1988; 73(3):179-81. PubMed ID: 2458996
    [No Abstract]   [Full Text] [Related]  

  • 36. Comparative effects of amifostine (Ethyol) on normal hematopoietic stem cells versus human leukemic cells during ex vivo purging in autologous bone marrow transplants.
    Douay L; Hu C; Giarratana MC; Gorin NC
    Semin Oncol; 1994 Oct; 21(5 Suppl 11):16-20. PubMed ID: 7973773
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro chemoseparation as part of autologous bone marrow transplantation (ABMT) in hematologic malignancy.
    Körbling M; Hunstein W
    Blut; 1984 Apr; 48(4):189-99. PubMed ID: 6370338
    [No Abstract]   [Full Text] [Related]  

  • 38. Survival and characteristics of murine leukaemic and normal stem cells after hyperthermia: a murine model for human bone marrow purging.
    Gidáli J; Szamosvölgyi S; Fehér I; Kovács P
    Leuk Res; 1990; 14(5):453-7. PubMed ID: 2345468
    [TBL] [Abstract][Full Text] [Related]  

  • 39. On the heterogeneity of minimal residual disease in acute leukemia.
    Hagenbeek A; Martens AC
    Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():9-12. PubMed ID: 2713565
    [No Abstract]   [Full Text] [Related]  

  • 40. Purging in autologous hematopoietic stem cell transplantation using adenosine triphosphate (ATP) and 4-hydroperoxycyclophosphamide (4-HC).
    Hatta Y; Itoh T; Baba M; Miyajima T; Shimojima H; Sawada U; Horie T
    Leuk Res; 2002 May; 26(5):477-82. PubMed ID: 11916522
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.